Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,118.0
-0.7 (-0.02%)

 

  • STI Straits Times Index
    3,118.0
    -0.7 (-0.02%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,556.5
    -8.3 (-0.53%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,857.5
    40.4 (0.14%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,566.7
    0.4 (0.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,875.2
    0.3 (0.00%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,019.6
    -15.0 (-0.25%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 941.7M
  • Value: 642.1M
  • Rise: 132
  • Fall: 154
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.006-
Tuan Sing0.530+0.055
YZJ Shipbldg SGD1.380-
MarcoPolo Marine0.028-
Trendlines0.111-
AP Strategic0.002-
Rex Intl0.188+0.003
Thomson Medical0.092+0.005
Metal Component0.057-0.002
Singtel2.310+0.010

World Indices

World Indices
Name Last Change
Nasdaq 14,271.7 +18.5
HSI 28,882.5 +65.4
HSCEI 10,677.3 +3.4
Jakarta 6,012.1 -22.5
Nikkei 225 28,875.2 +0.3
SSE Comp 3,566.7 +0.4
Shanghai A 3,738.5 +0.4
Shanghai B 253.5 +1.9
KOSPI 3,286.1 +9.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 24 Jun 2021 16:17
Last (SGD): 0.850 Change: -0.015 High: 0.860 Remarks: -
Change (%): -1.73 Low: 0.825
Open 0.860 Yesterday's Close 0.865
Buy Price 0.845 Sell Price 0.850
Buy Volume ('000) 66.0 Sell Volume ('000) 301.0
Cumulative Volume ('000) 5,786.0 Cumulative Value 4,861,619
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.31869 Trailing EPS (SGD) e 0.31869 NAV (SGD) b 0.4681
PE a 2.667 Trailing PE f 2.667 Price / NAV b 1.8159
Dividend (SGD) d 0.067474 Cash In Hand (SGD) g 0.1988 Issued & Paid-up Shares c 546,411,000
Dividend Yield (%) d 7.938 Price / Cash In Hand g 4.276 Treasury Shares h 3,000,000
Beta - 75 Daysi 0.115 R-Squared - 75 Days(%)i 0.13 Market Cap (M) 464.449
Beta - 500 Daysi -0.119 R-Squared - 500 Days (%)i 0.02 Enterprise Value (M) 398.755
Piotroski F Score 8 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 111.2906 6-Month VWAP 1.046 Free Float (%) 99.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 May 2021.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 464.449 2.667 2.667 1.8159 7.938
Industry Medical & Biotechnology SGX 952.285 19.976 16.950 1.3948 2.023
Medical Specialties SGX 2,038.221 15.713 4.054 4.6504 2.873
Index FTSE ST Catalist Index SGX 65.778 133.091 59.086 1.5517 1.555
Local Peer Top Glove SGX 11,286.404 18.589 4.043 5.1329 2.774
Local Peer UGHealthcare SGX 360.512 26.897 5.341 2.8384 0.388
Local Peer Biolidics SGX 74.327 - - 8.9744 -
Local Peer Yunnan Energy SGX 41.316 - - 1.1194 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer ABBOTT LABORATORIES NYSE 196,942.729 44.029 34.576 5.8680 1.376
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 194,163.693 30.457 24.503 5.5384 0.180
Global Peer DANAHER CORP NYSE 191,622.403 54.593 54.593 5.1579 0.267
Global Peer MEDTRONIC PLC NYSE 168,834.246 46.820 46.820 3.2829 1.849
Global Peer INTUITIVE SURGICAL INC NASDAQ 107,213.498 101.088 91.370 10.5593 -
Global Peer STRYKER CORP NYSE 98,949.095 61.882 70.276 7.3285 0.895
Global Peer BECTON DICKINSON & CO NYSE 69,860.540 91.083 42.598 2.8142 1.328
Global Peer EDWARDS LIFESCIENCES CORP NYSE 65,122.692 79.090 76.525 13.9796 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 62,221.649 - 435.116 3.9584 -
Global Peer IDEXX LABORATORIES INC NASDAQ 52,522.678 90.280 77.903 74.7445 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), AGILENT TECHNOLOGIES INC (NYSE), DEXCOM INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), NOVOCURE LTD (NASDAQ), WATERS CORP (NYSE), STERIS PLC (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), MICROPORT (HKEx), HOLOGIC INC (NASDAQ), ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), ANGELALIGN (HKEx), TOPGLOV (Bursa), GLOBUS MED INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), STAAR SURGICAL CO (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), HARTA (Bursa), NEVRO CORP (NYSE), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), CARDIOFLOW-B (HKEx), CAREDX INC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), QUIDEL CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), EBOS GROUP (ASX), INMODE LTD (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), HAEMONETICS CORP (NYSE), PEIJIA-B (HKEx), VERICEL CORP (NASDAQ), AXONICS INC (NASDAQ), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), SUPERMX (Bursa), ESTABLISHMENT LABS HLDGS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANOSONICS LIMITED (ASX), DERMTECH INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CIRC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), CHUNLI MEDICAL (HKEx), CRYOLIFE INC (NYSE), ATRION CORP (NASDAQ), 908 DEVICES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), BIOVENTUS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CERUS CORP (NASDAQ), VIEWRAY INC (NASDAQ), MODERN DENTAL (HKEx), AXOGEN INC (NASDAQ), KDL MEDICAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), ATOSSA THERAPEUTICS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), BASECARE-B (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), VAPOTHERM INC (NYSE), NEUROPACE INC (NASDAQ), PAVMED INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), ZYNEX INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ONCOCYTE CORP (NASDAQ), SOLITON INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), NEURONETICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SIENTRA INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), QUOTIENT LTD (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), IRADIMED CORP (NASDAQ), YESTAR HEALTH (HKEx), DARIOHEALTH CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CORMEDIX INC (NASDAQ), INVACARE CORP (NYSE), MEDICAL DEVELOPMENT INTL (ASX), APOLLO ENDOSURGERY INC (NASDAQ), AROA BIOSURGERY LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), TELA BIO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CYCLOPHARM LIMITED (ASX), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), PW MEDTECH (HKEx), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), VENUS CONCEPT INC (NASDAQ), VINCENT MED (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), SOMNOMED LIMITED (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), ALPHA PRO TECH (NYSE American), CHECK-CAP LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), BIOLASE INC (NASDAQ), IMPEDIMED LIMITED (ASX), OPTISCAN IMAGING (ASX), MICRO-X LTD (ASX), CELSION CORPORATION (NASDAQ), IRIDEX CORP (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), AVINGER INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), APPLIED UV INC (NASDAQ), NEPHROS INC (NASDAQ), ELECTROMED INC (NYSE American), LENSAR INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SDI LTD (ASX), VOLITIONRX LIMITED (NYSE American), ELECTROCORE INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), IMMUCELL CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), DELCATH SYSTEMS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), NEOVASC INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), YUNNAN ENERGY (HKEx), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RGTBHD (Bursa), PLUS THERAPEUTICS INC (NASDAQ), COMPUMEDICS (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CARDIEX LTD (ASX), RESONANCE HEALTH LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOMERICA INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ADVENTA (Bursa), DAXOR CORP (NYSE American), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIREMD INC (NASDAQ), RESPIRI LTD (ASX), RESHAPE LIFESCIENCES INC (NASDAQ), LKL (Bursa), DIMERIX LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NEUROTECH INTERNATIONAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), ADHERIUM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DYNATRONICS CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIFE HEALTHCARE (HKEx), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LBT INNOVATIONS LTD (ASX), TRUSCREEN GROUP LTD (ASX), CYANOTECH CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), METALICITY LIMITED (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ANALYTICA (ASX), DORSAVI LTD (ASX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.085
-9.09 %
10 Days --0.120
-12.37 %
20 Days --0.150
-15.00 %
Medium Term Return 3 Months 0.056-0.105
-5.13 %
6 Months 0.056-0.200
-13.71 %
1 Year 0.067+0.540
+195.81 %
Long Term Return 2 Years 0.067+0.825
+3568.00 %
3 Years 0.067+0.811
+2251.28 %
5 Years 0.067+0.802
+1810.42 %
Annualised Return Annualised --
+80.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.305 - 1.980 Change From 1 Year Low +0.545 % Change From 1 Year Low (%) +178.69
Change From 1 Year High -1.130 % Change From 1 Year High (%) -57.07
2 Years Range 0.023 - 1.980 Change From 2 Years Low +0.827 % Change From 2 Years Low (%) +3595.65
Change From 2 Years High -1.130 % Change From 2 Years High (%) -57.07
5 Years Range 0.022 - 1.980 Change From 5 Years Low +0.828 % Change From 5 Years Low (%) +3763.64
Change From 5 Years High -1.130 % Change From 5 Years High (%) -57.07
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +238.65 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Dec 2020 Part 1(5.09 MB)
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
23 Jun 2021 0.900 0.900 0.865 0.865 5,649,600 0.8789
22 Jun 2021 0.920 0.930 0.900 0.900 2,969,400 0.9112
21 Jun 2021 0.915 0.920 0.910 0.915 1,766,000 0.9127
18 Jun 2021 0.940 0.940 0.920 0.925 2,729,000 0.9271
17 Jun 2021 0.935 0.950 0.925 0.940 3,428,600 0.9353
16 Jun 2021 0.945 0.950 0.935 0.935 1,843,700 0.9419
15 Jun 2021 0.955 0.955 0.940 0.945 2,038,700 0.9476
14 Jun 2021 0.955 0.965 0.950 0.950 1,484,700 0.9559
11 Jun 2021 0.955 0.960 0.950 0.950 2,370,500 0.9547
10 Jun 2021 0.970 0.975 0.955 0.955 3,241,900 0.9617
09 Jun 2021 0.970 0.980 0.960 0.970 3,116,900 0.9705
08 Jun 2021 0.975 0.980 0.970 0.970 2,295,600 0.9735
07 Jun 2021 0.985 0.990 0.975 0.975 2,798,700 0.9807
04 Jun 2021 0.985 1.000 0.980 0.980 2,448,300 0.9854
03 Jun 2021 0.980 0.995 0.980 0.985 1,888,800 0.9867
02 Jun 2021 1.000 1.000 0.980 0.980 4,302,100 0.9908
01 Jun 2021 0.980 1.010 0.980 0.995 6,928,300 0.9954
31 May 2021 0.995 1.000 0.980 0.980 3,032,500 0.9895
28 May 2021 0.995 1.010 0.990 0.990 4,224,800 0.9952
27 May 2021 1.000 1.020 0.990 0.990 6,894,200 1.0035
25 May 2021 0.990 1.010 0.980 1.000 8,911,000 0.9939
24 May 2021 1.010 1.010 0.980 0.990 7,796,300 0.9881
Summary
Current 2 Weeks
(10 Jun 2021 to 23 Jun 2021)
0.970 0.975 0.865 0.865 27,522,100 -
Previous 2 Weeks
(27 May 2021 to 09 Jun 2021)
1.000 1.020 0.865 0.970 37,930,200 -
4 Weeks from
(27 Apr 2021 to 25 May 2021)
1.140 1.150 0.865 1.000 261,161,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.